Actuate Therapeutics Inc

ACTU

ACTUActuate Therapeutics Inc US flag

NASDAQ Global Market

1.35

USD

-0.05

- -

32.30MMarket Cap

Income Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -
- Operating Expenses	20	25	25	22
+ Selling, General & Admin	4	3	6	12
+ Research & Development	16	22	19	10
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	-20	-25	-25	-22
- Non-Operating (Income) Loss	- -	- -	2	- -
+ Interest Expense, Net	- -	- -	- -	- -
+ Interest Expense	- -	- -	- -	- -
- Interest Income	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	- -	2	- -
Pretax Income	-20	-25	-27	-22
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	-20	-25	-27	-22
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	-20	-25	-27	-22
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	-20	-25	-27	-22
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-20	-25	-27	-22
EBIT	-20	-25	-25	-22
EBITDA	-20	-25	-25	-22
EBITDA Margin (%)	- -	- -	- -	- -
EBITA	-20	-25	-25	-22
Gross Margin (%)	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -
Basic Weighted Avg Shares	15	19	8	21
Basic EPS, GAAP	-1.34	-1.29	-3.26	-1.06
Basic EPS from Cont Ops	-1.34	-1.29	-3.26	-1.06
Diluted Weighted Avg Shares	15	19	8	21
Diluted EPS, GAAP	-1.34	-1.29	-3.26	-1.06
Diluted EPS from Cont Ops	-1.34	-1.29	-3.26	-1.06

Balance Sheet (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Current Assets	20	3	9	14
+ Cash, Cash Equivalents & STI	20	3	9	13
+ Cash & Cash Equivalents	20	3	9	13
+ ST Investments	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	- -	- -	1	- -
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	- -	- -
+ Property, Plant & Equip, Net	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	- -
+ Total Intangible Assets	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -
Total Assets	20	3	9	14
+ Payables & Accruals	4	7	8	5
+ Accounts Payable	2	3	2	2
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	2	3	6	4
+ ST Debt	- -	- -	- -	- -
+ ST Borrowings	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	1	1
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	1	1
Total Current Liabilities	4	7	9	6
+ LT Debt	- -	- -	- -	- -
+ LT Borrowings	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -
+ Other LT Liabilities	91	96	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	91	96	- -	- -
Total Noncurrent Liabilities	91	96	- -	- -
Total Liabilities	96	103	9	6
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	5	5	132	163
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	5	5	132	163
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-80	-105	-132	-155
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-75	-100	- -	8
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-75	-100	- -	8
Total Liabilities & Equity	20	3	9	14
Shares Outstanding	19	19	20	23
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -
Net Debt	-20	-3	-9	-13
Net Debt to Equity	27.16	2.97	-8,294.42	-166.07
Tangible Common Equity Ratio	-367.65	-3,325.8	1.12	56.46
Current Ratio	4.71	0.43	1.05	2.39
Cash Conversion Cycle	- -	- -	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

+ Net Income	-20	-25	-27	-22
+ Depreciation & Amortization	- -	- -	- -	- -
+ Non-Cash Items	1	1	4	6
+ Stock-Based Compensation	1	- -	2	6
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	2	- -
+ Chg in Non-Cash Work Cap	2	3	1	-3
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	-1	- -
+ Inc (Dec) in Accts Payable	2	3	2	-3
+ Inc (Dec) in Other	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	-18	-22	-22	-19
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	24	24
+ Increase in Capital Stock	- -	- -	24	24
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	- -
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	6	- -
+ Cash From Debt	- -	- -	6	- -
+ Repayments of Debt	- -	- -	- -	- -
+ Other Financing Activities	19	4	-2	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	19	4	28	24
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	1	-17	6	5
EBITDA	-20	-25	-25	-22
EBITDA Margin (%)	- -	- -	- -	- -
Free Cash Flow	-18	-22	-22	-19
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-22	-16	-19
Free Cash Flow per Basic Share	-1.18	-1.13	-2.61	-0.91
Price/Free Cash Flow	- -	- -	-3.05	-6.7
Cash Flow to Net Income	0.88	0.87	0.8	0.86
Capital Expenditures	- -	- -	- -	- -